Associated Papers
EYA2 suppresses the progression of hepatocellular carcinoma via SOCS3-mediated blockade of JAK/STAT signaling.
Liu ZK et al.
Molecular Cancer, 2021
34044846 (PubMed )
Supplement: 12943_2021_1377_MOESM2_ESM.zip › Additional_file_2-Table_S3.xlsx › non-silent_mutations_and_indel
UBE2S interacting with TRIM28 in the nucleus accelerates cell cycle by ubiquitination of p27 to promote hepatocellular carcinoma development.
Zhang RY et al.
Signal Transduction and Targeted Therapy, 2021
Select a paper to view details